ACCORDENGAGE Trademark

Trademark Overview


On Thursday, April 13, 2023, a trademark application was filed for ACCORDENGAGE with the United States Patent and Trademark Office. The USPTO has given the ACCORDENGAGE trademark a serial number of 97887297. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, October 17, 2024. This trademark is owned by Accord BioPharma, Inc.. The ACCORDENGAGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the nature of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials
accordengage

General Information


Serial Number97887297
Word MarkACCORDENGAGE
Filing DateThursday, April 13, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesProviding medical and scientific research information in the nature of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAccord BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617

Party NameAccord BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Monday, April 17, 2023NEW APPLICATION ENTERED
Monday, May 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Friday, January 19, 2024NON-FINAL ACTION WRITTEN
Friday, January 19, 2024NON-FINAL ACTION E-MAILED
Friday, January 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU EXTENSION 1 FILED
Thursday, October 17, 2024SOU EXTENSION 1 GRANTED